Literature DB >> 10337496

CombiTool--a new computer program for analyzing combination experiments with biologically active agents.

V Dressler1, G Müller, J Sühnel.   

Abstract

CombiTool is a new computer program for the analysis of combination effects of biologically active agents. It performs model calculations and an analysis of experimental combination effects for two or three agents according to both the Bliss independence and the Loewe additivity criteria. Zero interaction response surfaces are calculated from single-agent dose-response relations and compared to experimental combination data. The calculation of response surfaces for Loewe additivity is based on a new approach which combines the implicit definition equation in terms of doses alone with single-agent dose-response relations. The simultaneous analysis of experimental data according to both Loewe additivity and Bliss independence within one program can hopefully contribute to a better understanding of the meaning and limits of the two criteria. CombiTool has a built-in graphics facility which allows the direct visualization of the response surfaces or the corresponding contour plots and the experimental data.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10337496     DOI: 10.1006/cbmr.1999.1509

Source DB:  PubMed          Journal:  Comput Biomed Res        ISSN: 0010-4809


  12 in total

Review 1.  A few specialized issues that should be focused on anti-HIV drug evaluation in vitro.

Authors:  Dao-min Zhuang; Jing-yun Li
Journal:  Virol Sin       Date:  2010-07-28       Impact factor: 4.327

Review 2.  Predictive approaches for drug combination discovery in cancer.

Authors:  Seyed Ali Madani Tonekaboni; Laleh Soltan Ghoraie; Venkata Satya Kumar Manem; Benjamin Haibe-Kains
Journal:  Brief Bioinform       Date:  2018-03-01       Impact factor: 11.622

3.  The hepatitis C virus (HCV) NS4B RNA binding inhibitor clemizole is highly synergistic with HCV protease inhibitors.

Authors:  Shirit Einav; Hadas D Sobol; Elizabeth Gehrig; Jeffrey S Glenn
Journal:  J Infect Dis       Date:  2010-07-01       Impact factor: 5.226

4.  A monoclonal antibody targeted against epidermal growth factor receptor variant III enhances cisplatin efficiency.

Authors:  Na Li; Yuanyuan Chu; Liangqing Yao; Xiaojun Ying; Hua Jiang; Ming Zhou; Congjian Xu
Journal:  J Cancer Res Clin Oncol       Date:  2011-08-02       Impact factor: 4.553

5.  The selective SYK inhibitor P505-15 (PRT062607) inhibits B cell signaling and function in vitro and in vivo and augments the activity of fludarabine in chronic lymphocytic leukemia.

Authors:  Stephen E Spurgeon; Greg Coffey; Luke B Fletcher; Russell Burke; Jeffrey W Tyner; Brian J Druker; Andreas Betz; Francis DeGuzman; Yvonne Pak; Dale Baker; Anjali Pandey; Stanley J Hollenbach; Uma Sinha; Marc M Loriaux
Journal:  J Pharmacol Exp Ther       Date:  2012-12-07       Impact factor: 4.030

6.  Combinations of adefovir with nucleoside analogs produce additive antiviral effects against hepatitis B virus in vitro.

Authors:  William E Delaney; Huiling Yang; Michael D Miller; Craig S Gibbs; Shelly Xiong
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

7.  Enhancement of glioma radiotherapy and chemotherapy response with targeted antibody therapy against death receptor 5.

Authors:  John B Fiveash; G Yancey Gillespie; Patsy G Oliver; Tong Zhou; Michael L Belenky; Donald J Buchsbaum
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-06-01       Impact factor: 7.038

8.  Inhibition of ion channels and heart beat in Drosophila by selective COX-2 inhibitor SC-791.

Authors:  Roman V Frolov; Satpal Singh
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

9.  In vitro activity and resistance profile of samatasvir, a novel NS5A replication inhibitor of hepatitis C virus.

Authors:  J P Bilello; L B Lallos; J F McCarville; M La Colla; I Serra; C Chapron; J M Gillum; C Pierra; D N Standring; M Seifer
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

Review 10.  International issues on human health effects of exposure to chemical mixtures.

Authors:  Victor J Feron; Flemming R Cassee; John P Groten; Petronella W van Vliet; Job A van Zorge
Journal:  Environ Health Perspect       Date:  2002-12       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.